Our View
中文Our View is our own analysis of a company: the argument, the facts it rests on, the other side, and scenarios for 2030 with probabilities from our model, all built on stated assumptions (how to read the scenario numbers). It is opinion, not investment advice: we never tell you to buy or sell a stock. Don't see a stock? Request it →
-
Moderna: what today's price assumes about its cancer platform
Our analysis of Moderna after its cancer-vaccine success and Analyst Day: what the price assumes about its platform, and what 50,000 simulations say about end-2030 value.
-
Coinbase: our view and what our model says about 2030
Our analysis of Coinbase after Q3: crypto trading, USDC income, prediction markets, stock pay and what 50,000 simulations say about end-2030 value.
-
Alnylam: our view and what our model says about 2030
Our analysis of Alnylam after Q3: slower Amvuttra demand, the 340B and payer pressure, the new buyback and what 50,000 simulations say about end-2030 value.
-
Palantir: our view and what our model says about 2030
Our analysis of Palantir after Q3: slower contract signings, a thin contracted backlog, its high multiple and what 50,000 simulations say about end-2030 value.
-
Astera Labs: our view and what our model says about 2030
Our analysis of Astera Labs after its Q3 results: the Scorpio ramp, customer concentration, stock pay and what 50,000 simulations say about its end-2030 value.
-
Madrigal: our view and what our model says about 2030
Our analysis of Madrigal after its first profitable quarter: patient growth, rebates, the cirrhosis trial and what 50,000 simulations say about its end-2030 value.
-
Viking: our view and what our model says about 2030
Our analysis of Viking Therapeutics: what its obesity drug must deliver, the cash to get there, and what 50,000 simulations say about its end-2030 value.
-
Nvidia: our view and what our model says about 2030
Our analysis of Nvidia: growth backed to fiscal 2028, the new risk of customer financing, and what 50,000 simulations say about its value at the end of 2030.